During Monday’s Current trade, Shares of Merck & Co., Inc. (NYSE:MRK), gain 1.04% to $52.62.
Merck will present new data on early- and late-stage compounds from its refocused oncology and immuno-oncology pipeline, in addition to Erbitux® (cetuximab) data, at this year’s European Cancer Congress (ECC), held in Vienna, Austria , from September 25-29, 2015 .
Collaborating to Address Patient Needs
Two important planned collaborations presenting data in challenging cancers at ECC this year are the Merck-Pfizer Alliance, and Merck’s partnership with Threshold Pharmaceuticals, Inc.
The Merck-Pfizer Alliance will present six abstracts on studies evaluating the potential role of PD-L1 inhibition, and the safety and efficacy of the investigational cancer immunotherapy avelumab. New data on this immune checkpoint inhibitor will be presented in urothelial (e.g. bladder), mesothelioma and gastric/gastroesophageal cancers. Additional non-small cell lung and ovarian cancer data from Phase Ib trials build on those formerly presented at the 2015 Annual Meeting of the American Society of Clinical Oncology.[1-10]
Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. It also offers neuromuscular blocking agents for use in surgery; anti-bacterial products for skin and skin structure infections; antidepressants; ophthalmic and cholesterol modification products; non-sedating antihistamine; and vaginal contraceptive implants. In addition, the company provides products to prevent chemotherapy-induced and post-operative nausea and vomiting; to treat brain tumors and melanoma; to prevent diseases caused by human papillomavirus, in addition to vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases.
Shares of Centurylink Inc (NYSE:CTL), declined -0.95% to $26.02, during its current trading session.
Harte Hanks (NYSE: HHS), a leader in developing customer relationships, experiences and defining interaction-led marketing, recently declared the appointment of Karen Puckett as its President and Chief Executive Officer, effective right away.
Ms. Puckett, 55, a director of Harte Hanks since 2009, will remain a director but will no longer serve on the Compensation Committee. Ms. Puckett succeeds interim President and CEO Doug Shepard, who will continue in his role as Harte Hanks’ Chief Financial Officer.
Ms. Puckett brings noteworthy experience in the telecom, cloud and managed services industries in both consumer and business segments, stemming from her 15-year tenure at CenturyLink, Inc. (NYSE: CTL), where she served as the Chief Operating Officer from 2000 - 2014, and as President - Global Markets from then until leaving the company in August to pursue new leadership opportunities.
During her time at CenturyLink, she was instrumental in leading its transformation from a local telephone company to an industry leader in advanced communications services and driving revenue growth from $1.5 billion to over $18 billion. Furthermore, she is an practiced business integrator, having overseen 15 acquisitions during her time at CenturyLink. In addition to serving on the board of Harte Hanks, Ms. Puckett also sits on the board of Entergy Corporation, a Fortune 500 electric utilities company.
CenturyLink, Inc. provides various communications services to residential, business, governmental, and wholesale customers in the United States. It operates through two segments, Business and Consumer. The company offers broadband services, which allow customers to connect to the Internet through their existing telephone lines or fiber-optic cables; private line services for transmission of large amounts of data between sites; and multi-protocol label switching, a data networking technology to support real-time voice and video.
Home Depot In c(NYSE:HD), during its Monday’s current trading session decreased -0.03% to $115.41.
The Home Depot Canada Foundation’s month-long Celebration of Service campaign kicks-off recently, with our associate-led volunteer force “Team Depot” taking on renovation projects that assist local youth-serving organizations provide safe and stable housing, and supportive services for homeless youth.
As part of the Foundation’s three-year, $10-million pledge to assist end youth homelessness in Canada, Team Depot volunteers partner with local youth-serving organizations throughout the month of September, taking on more than 100 renovation projects across the country. Projects such as installing a new kitchen, painting and refreshing common living areas and planting gardens and green spaces assist these facilities feel more like home, and supports local youth-serving organizations as they provide much-needed life skills development and job training for homeless youth.
The Home Depot, Inc. operates as a home improvement retailer. It operates The Home Depot stores that sell various building materials, home improvement products, and lawn and garden products, in addition to provide installation, home maintenance, and professional service programs to do-it-yourself, do-it-for-me, and professional customers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
